Zura Bio Limited Stock Fundamentals
ZURA Stock | 1.28 0.20 18.52% |
Zura Bio Limited fundamentals help investors to digest information that contributes to Zura Bio's financial success or failures. It also enables traders to predict the movement of Zura Stock. The fundamental analysis module provides a way to measure Zura Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zura Bio stock.
At present, Zura Bio's Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 75.6 M, whereas Operating Income is projected to grow to (53.6 M). Zura | Select Account or Indicator |
Zura Bio Limited Company Shares Owned By Institutions Analysis
Zura Bio's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Zura Bio Shares Owned By Institutions | 53.29 % |
Most of Zura Bio's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zura Bio Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 53% of Zura Bio Limited are shares owned by institutions. This is 19.38% higher than that of the Biotechnology sector and 12.19% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 35.91% lower than that of the firm.
Zura Bio Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zura Bio's current stock value. Our valuation model uses many indicators to compare Zura Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zura Bio competition to find correlations between indicators driving Zura Bio's intrinsic value. More Info.Zura Bio Limited is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Zura Bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zura Bio's earnings, one of the primary drivers of an investment's value.Zura Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zura Bio's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zura Bio could also be used in its relative valuation, which is a method of valuing Zura Bio by comparing valuation metrics of similar companies.Zura Bio is currently under evaluation in shares owned by institutions category among its peers.
Zura Fundamentals
Return On Equity | -0.37 | ||||
Return On Asset | -0.21 | ||||
Current Valuation | 70.86 M | ||||
Shares Outstanding | 63.77 M | ||||
Shares Owned By Insiders | 31.87 % | ||||
Shares Owned By Institutions | 53.29 % | ||||
Number Of Shares Shorted | 5.13 M | ||||
Price To Book | 0.46 X | ||||
EBITDA | (60.56 M) | ||||
Net Income | (60.56 M) | ||||
Total Debt | 21.29 M | ||||
Book Value Per Share | 2.34 X | ||||
Cash Flow From Operations | (15.05 M) | ||||
Short Ratio | 5.43 X | ||||
Earnings Per Share | 0.57 X | ||||
Target Price | 15.0 | ||||
Number Of Employees | 14 | ||||
Beta | 0.14 | ||||
Market Capitalization | 295.78 M | ||||
Total Asset | 100.84 M | ||||
Retained Earnings | (103.49 M) | ||||
Working Capital | 80.54 M | ||||
Net Asset | 100.84 M |
About Zura Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zura Bio Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zura Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zura Bio Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | -320 K | -336 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:Check out Zura Bio Piotroski F Score and Zura Bio Altman Z Score analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.